Core 3 – Interventions in Humans

Investigators using Core 3 seek to build capacity for early and later-phase multi-site clinical trials through strategic partnerships. Resources include technologies in imaging, genomic research, biomarkers, and informatics. Core 3 will also leverage existing partnerships to form and support a Phase I clinical testing facility. 

Shared Research Resources